Clair Labs
- Industry
- Remote Patient Monitoring Technology
- Founded Year
- 2017
- Headquarters
- 41 Gershon Shatz, Tel Aviv, Israel
- Employee Count
- 11
Key People
-
Ariel Beery - Co-Founder and CEO
LinkedIn: https://www.linkedin.com/in/arielbeery/
- Dr. Daniel Aronovich - Co-Founder and CTO
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The founding team comprises individuals with over a decade of experience in their respective fields.
Ariel Beery and Dr. Daniel Aronovich bring significant experience to Clair Labs, enhancing the company's potential for success.
- Clinical Need
-
Aspect: Very Strong
Summary: The demand for remote patient monitoring solutions is high, addressing critical healthcare needs.
With the increasing prevalence of chronic diseases and the need for continuous monitoring, Clair Labs' solutions meet a significant clinical need.
- Competition
-
Aspect: Somewhat crowded
Summary: The remote patient monitoring market has several players, indicating moderate competition.
While the market is competitive, Clair Labs can leverage its unique technology to stand out.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing contact-free biomarker sensing involves moderate technical challenges.
The company's focus on non-invasive monitoring presents technical challenges that are manageable with the right expertise.
- Patent
-
Aspect: Applied
Summary: The company has applied for patents to protect its technology.
By securing patents, Clair Labs aims to protect its intellectual property and gain a competitive edge.
- Financing
-
Aspect: Medium
Summary: The company has secured moderate funding from reputable investors.
While initial funding supports development, further investment will be crucial for market expansion.
- Regulatory
-
Aspect: Running FIH
Summary: The company is conducting first-in-human trials for its technology.
Advancing to first-in-human trials demonstrates the technology's potential and readiness for further development.
Opportunity Rollup
- Odds of Success
- 3.85
- Peak Market Share
- 5.2
- Segment CAGR
- 18%
- Market Segment
- Remote Patient Monitoring
- Market Sub Segment
- Contact-Free Biomarker Sensing
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.26 |
| 2 | 0.78 |
| 3 | 1.82 |
| 4 | 3.64 |
| 5 | 5.20 |
Key Takeaway
Clair Labs is well-positioned in the growing remote patient monitoring market, leveraging innovative technology to meet critical healthcare needs.